Skip to main content
Caplight Logo









Enjamb Labs

Enjamb Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://enjamb.ai

Last Round

Seed

Apr 14, 2026

Total Funding Raised

$650,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Enjamb Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in April 2026.

Enjamb Labs is a software company that provides an AI-powered workforce platform designed for biopharma research and development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Workflow Automation, Data Integration, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Enjamb Labs Comparables

Compare Enjamb Labs with similar companies based on industry and business-model similarity.

Enjamb Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scoop
86%
Delineate
83%
Octozi
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Enjamb Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 14, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Enjamb Labs Investors

Notable investors and investment history

Enjamb Labs investors
InvestorRounds
Founders, Inc.Seed
Y CombinatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    $650K round with Founders, Inc. and Y Combinator.

Book a demo to see all signals

For institutional investors. Book with your work email.

Enjamb Labs Filings

Explore SEC and related filing metadata, where available.

Enjamb Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Enjamb Labs's valuation, stock price, and market status.

Is Enjamb Labs a public or private company?

Enjamb Labs is a private company.

What is the current stock price of Enjamb Labs?

Enjamb Labs is a private company, so its shares have no public market price. Caplight tracks Enjamb Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Enjamb Labs worth (valuation)?

Valuation information for Enjamb Labs is not publicly available.

Can I buy Enjamb Labs stock?

Enjamb Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Enjamb Labs's last funding round?

Enjamb Labs's most recent funding round was Seed on April 14, 2026.

Who are the main investors in Enjamb Labs?

Key investors in Enjamb Labs include Founders, Inc., Y Combinator.

Will Enjamb Labs IPO soon?

No public IPO plans have been announced for Enjamb Labs.

How can I track Enjamb Labs secondary market activity?

Caplight tracks bids, offers, and trades in Enjamb Labs's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2025
Last FundingApr 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?